Cell-type-resolved genetic variation shapes inflammatory bowel disease risk

Researchers published findings on June 3, 2026, in Nature, detailing how cell-type-specific genetic variations influence the risk of inflammatory bowel disease (IBD). The study employed single-cell mapping of cis-expression quantitative trait loci (cis-eQTLs) to identify these variations. Their analysis revealed that distal variants, particularly those enriched in enhancers, were more frequently co-localized with genome-wide association study (GWAS) loci when examined at the cell-type level compared to analyses conducted at the whole-tissue level. This granular approach allowed for a more precise understanding of how genetic predispositions manifest in specific cellular environments within the gut. The research highlights the importance of considering cellular heterogeneity when dissecting the genetic architecture of complex diseases like IBD. By distinguishing the effects of genetic variants across different cell types, the study provides a refined map of IBD risk loci, potentially leading to more targeted therapeutic strategies. The findings underscore a significant advancement in the field of complex trait genetics, emphasizing the power of single-cell resolution in uncovering disease mechanisms.